Help us stop stockpiling

the word diabetes is written on a chalkboard
Amid concerns about disruption to insulin availability, another supplier has moved to reassure pharmacists and prescribers Sanofi has issued a statement in which it says it can assure health care professionals that the company is not experiencing any shortages of insulin glargine 100 units/mL in Australia as a result of the COVID-19 pandemic. Sanofi has

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous How much has Australia really flattened the curve of coronavirus?
Next Cleaning, distancing, split teams and more